Home / Anti-infectives / Cefepime
ATC J01DE01 · Fourth-Generation Cephalosporins
Cefepime shortage
As of 2 Nov 2026, Cefepime has a reported shortage in 2 of the 15 countries we track (United States, Canada), covering 3 products from 2 companies.
Countries2/15
Products3packs or presentations
Companies21 listed
Short since23 Aug 201214.2 years ago
Earliest returnnot givencompany estimate
Main reasonNot stated
United States2 products shortCanada1 product shortGermanyNo reported shortageFranceNo reported shortageItalyNo reported shortageSpainNo reported shortageIrelandNo reported shortageAustriaNo reported shortageBelgiumNo reported shortageSwitzerlandNo reported shortageCzechiaNo reported shortageNorwayNo reported shortageSwedenNo reported shortageJapanNo reported shortageAustraliaNo reported shortage
Timeline
United StatesCanada
Solid bars run from the reported start to today; faded bars show the time left until the expected return. An arrow means no return date was given.
Which companies are short
products short, all countriesListed: Fresenius Kabi FRE · Xetra
Compared with similar medicines
ATC group J01DE · Fourth-Generation CephalosporinsAffected products
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Cefepime Hydrochloride, Injection, 1 g (NDC 63323-326-20) discontinuation | Fresenius Kabi USA, LLC | 10 Feb 2026 | not given | Not stated |
| US | Cefepime Hydrochloride, Injection, 2 g (NDC 63323-340-20) discontinuation | Fresenius Kabi USA, LLC | 10 Feb 2026 | not given | Not stated |
| CA | CEFEPIME FOR INJECTION (20 ML) | APOTEX INC | 23 Aug 2012 | not given | Manufacturing problem Disruption of the manufacture of the drug |
"Expected back" is the date the company gave the authority, when it gave one. Ask a pharmacist about alternatives.